Mucositis in Immunocompromised Hosts: No Association Between Mucositis and Mucosal Barrier Integrity Organism Detection on Plasma Next Generation Sequencing

Clicks: 14
ID: 327332
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #102 of 147 articles by views in journal of the pediatric infectious diseases society

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 147 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Plasma next generation sequencing (pNGS) for microbial organisms is useful in the workup of immunocompromised hosts with suspected infection. However, the interpretation of pNGS is still an area of investigation. PNGS results often include bacteria/fungi know to colonize the gastrointestinal (GI) tract. The clinical relevance of these results, especially in immunocompromised patients, is unclear. We hypothesized that patients with mucositis would be more likely to have increased detection rates of microorganisms that colonize the GI tract due to barrier disruption leading to transient bacteremia. Methods Inpatient pNGS (KariusTM) results over four-years (3/2020-10/2024) were reviewed retrospectively. Patients with malignancy or receiving hematopoietic stem cell transplant (HSCT) were included. Patient data was extracted from electronic charts into REDCapTM. Statistical analyses (descriptive, Fisher t-test, Mann-Whitney U) were performed with GraphPad PRISM. A Pediatric Oncologist specified criteria for mucositis and adjudication complex or unclear cases. Results Eighty-three pNGS tests met inclusion criteria. Nineteen tests (22.9%) detected organisms classified as Mucosal-Barrier-Injury-Associated (MBI) by the National Healthcare Safety Network (Table 1). There was no association between MBI detection and presence of mucositis, neutropenia, cancer diagnosis, ICU admission, or symptoms. Patients with MBI were older than non-MBI patients (median age 16 vs 10.5 years, p=0.0142). MBI organism detections were more likely to lead to a diagnosis (p=0.044) and prompt antibiotic changes (p=0.0025). MBI detection was less common in HSCT patients (10.5%, p=0.0488). Eighteen tests occurred in patients with documented mucositis (Table 2). Although not associated with MBI detection, mucositis was correlated with GI symptoms, skin findings, and febrile neutropenia. Other examined patient factors were not different between patients with and without mucositis. Conclusion Contrary to our hypothesis, mucositis was not associated with increased detection of MBI organisms by pNGS. Despite prolonged neutropenia and presumed higher risk of mucosal disruption and infections, HSCT and AML patients had very low rates of MBI detection (3/19, 15.7%), likely related to antibiotic prophylaxis and close inpatient monitoring during ANC nadirs. At this institution, detection of MBI organisms was often interpreted as clinically relevant and leds to antibiotic changes. These conclusions are limited by small sample size and single center design. Future studies could examine the role of mucositis severity, duration of neutropenia, infection-related mortality. Antibiotic exposure as a potential confounder should be further investigated. This study raises important questions on the relationship between clinical symptoms and MBI detections among the immunocompromised for which further study is needed.
Reference Key
openalex_W7204651881 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kathleen Condon, Heather Valdin, Emily McGee, Hena Brucia, J. Schieffelin, Margarita Silió
Are you one of these authors? Claim your profile
Journal journal of the pediatric infectious diseases society
Year 2026
DOI
10.1093/jpids/piag070/piag070.072
URL
https://academic.oup.com/jpids/article-pdf/15/Supplement_2/S31/70833381/piag070.072.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.